Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing–remitting MS

[1]  G. Pellicanò,et al.  Short‐term evolution of autoreactive T cell repertoire in multiple sclerosis , 2001, Journal of neuroscience research.

[2]  Marco Rovaris,et al.  Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.

[3]  J. Kappler,et al.  T Cell Receptor (Tcr)-Mediated Repertoire Selection and Loss of Tcr Vβ Diversity during the Initiation of a Cd4+ T Cell Response in Vivo , 2000, The Journal of experimental medicine.

[4]  W. Oertel,et al.  Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. , 2000, Journal of immunological methods.

[5]  J. Frank,et al.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.

[6]  J H Simon,et al.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.

[7]  Roland Martin,et al.  Human Autoreactive CD4+ T Cells from Naive CD45RA+ and Memory CD45RO+ Subsets Differ with Respect to Epitope Specificity and Functional Antigen Avidity , 2000, The Journal of Immunology.

[8]  R. Hohlfeld,et al.  Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. , 2000, Brain : a journal of neurology.

[9]  T. Murray,et al.  Does a shift in the T-cell receptor repertoire precede the onset of MS? , 1999, Neurology.

[10]  L. Amaducci,et al.  Detection of skewed T-cell receptor V-β gene usage in the peripheral blood of patients with multiple sclerosis , 1998, Journal of Neuroimmunology.

[11]  M. Rewers,et al.  Prevalence of CD8+ T-cell expansions in relation to age in healthy individuals. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  Roland Martin,et al.  Lack of over-expression of T cell receptor Vβ5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controls , 1998, Journal of Neuroimmunology.

[13]  A. McMichael,et al.  Multiple T cell expansions are found in the blood and synovial fluid of patients with reactive arthritis. , 1997, The Journal of rheumatology.

[14]  S. Jacobson,et al.  Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. , 1997, Journal of immunology.

[15]  D E Banks,et al.  Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. , 1997, The Journal of clinical investigation.

[16]  P. Kourilsky,et al.  Expanded CD4+ and CD8+ T cell clones in elderly humans. , 1997, Journal of immunology.

[17]  J. Bell,et al.  Large clonal expansions of CD8+ T cells in acute infectious mononucleosis , 1996, Nature Medicine.

[18]  D. Hafler,et al.  TCR usage in human and experimental demyelinating disease. , 1996, Immunology today.

[19]  U. Utz,et al.  Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion , 1996, Journal of virology.

[20]  Tak W. Mak,et al.  Human T-cell receptor variable gene segment families , 1995, Immunogenetics.

[21]  P. Gregersen,et al.  Oligoclonality in the Human CD8+ T Cell Repertoire in Normal Subjects and Monozygotic Twins: Implications for Studies of Infectious and Autoimmune Diseases , 1995, Molecular medicine.

[22]  B. Kotzin,et al.  Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. , 1995, Journal of immunology.

[23]  D. Hafler,et al.  Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. , 1994, Journal of immunology.

[24]  J. Kappler,et al.  Genetic analysis of low V beta 3 expression in humans , 1994, The Journal of experimental medicine.

[25]  H. Reyburn,et al.  Bimodal distribution of Vβ2+CD4+ T cells in human peripheral blood , 1994 .

[26]  D. Bourdette,et al.  T cell receptor Vβ gene usage in the recognition of myelin basic protein by cerebrospinal fluid‐ and blood‐derived T cells from patients with multiple sclerosis , 1994 .

[27]  U. Utz,et al.  Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis , 1993, Nature.

[28]  T. Rème,et al.  Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients , 1993, The Journal of experimental medicine.

[29]  D. Schoenfeld,et al.  The human T-cell receptor β-chain repertoire: longitudinal fluctuations and assessment in MHC matched populations , 1993, Immunogenetics.

[30]  Roland Martin,et al.  Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.

[31]  T. Nakajima,et al.  Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. , 1992, International immunology.

[32]  B. V. Van Ness,et al.  Quantitation of T‐cell receptor Vβ chain expression on lymphocytes from blood, brain, and spinal fluid in patients with multiple sclerosis and other neurological diseases , 1992 .

[33]  E. D. Robinson,et al.  Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. , 1992, Journal of immunology.

[34]  E. Meinl,et al.  Diversity of T cell receptor α and β chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes , 1992 .

[35]  G. Nedwin,et al.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Weiner,et al.  T-cell recognition of myelin basic protein. , 1991, Immunology today.

[37]  A. Ben-nun,et al.  Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Weiner,et al.  Common T‐cell receptor Vβ usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis , 1991, Annals of neurology.

[39]  P. Marrack,et al.  Selective expansion of T cells expressing V beta 2 in toxic shock syndrome , 1990, The Journal of experimental medicine.

[40]  J. Seidman,et al.  Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. , 1990, Science.

[41]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[42]  E. Heber-Katz,et al.  The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. , 1989, Immunology today.

[43]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[44]  H. McFarland,et al.  Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. , 1995, Critical reviews in clinical laboratory sciences.